spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  NPS Pharmaceuticals 

 HSMN NewsFeed - 21 Jun 2022
Chemomab Therapeutics Appoints Jill M. Quigley, JD, to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Nov 2021
INOVIO Expands Executive Leadership to Prepare for Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Apr 2020
PTC Therapeutics Announces New Leadership Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 May 2019
U.S. FDA Approves GATTEX(R) (teduglutide) for Children 1 Year of Age and Older With Short Bowel Syndrome (SBS)
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 8 Nov 2018
OncoSec Appoints Robert Ward to its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Jul 2018
OncoSec Appoints Robert W. Ashworth, Ph.D. as Vice President, Regulatory
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Dec 2017
Eloxx Pharmaceuticals Appoints Robert Ward Chairman and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jun 2017
PTC Therapeutics Announces Executive Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 May 2017
Shire and Parion Sciences Enter into a Collaborative License Agreement to Advance P-321 for Ophthalmic Indications
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 16 Mar 2017
Shire Receives European Approval for Label Extension of CINRYZE(R) (C1 inhibitor ) to Prevent and Treat Hereditary Angioedema (HAE) Attacks in Paediatric Patients with HAE
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Dec 2016
Shire Announces FDA Approval of Adynovate(R) for use in Children and Surgical Settings
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Oct 2016
Shire Granted EU Marketing Authorization of Onivyde(R), in Combination With 5-Fluorouracil (5-FU) and Leucovorin (LV),for the Treatment of Metastatic Adenocarcinoma of the Pancreas in Adult Patients Who Have Progressed Following Gemcitabine-Based Therapy
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 7 Jul 2016
Shire Receives Extension of Market Authorization in Europe for Revestive(R) (Teduglutide) for the Treatment of Paediatric Patients with Short Bowel Syndrome (SBS)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 29 Mar 2016
Shire Wins Patent Trial Against Watson Concerning LIALDA(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 8 Feb 2016
Global Blood Therapeutics Announces Changes to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Nov 2015
Shire to Acquire Dyax Corp, Expanding and Extending Industry-Leading Hereditary Angioedema (HAE) Portfolio
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Sep 2015
Momenta Pharmaceuticals Appoints Georges Gemayel, Ph.D., to Board of Directors
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 2 Sep 2015
Summit Therapeutics Appoints Ralf Rosskamp, MD, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jul 2015
Baxalta Appoints Two New Directors to the Board, Further Diversifying With Strong Biopharmaceutical Leadership Experience
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Apr 2015
PTC Therapeutics Names Eric Pauwels SVP & General Manager Commercial Operations, Americas
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2015
Iroko Pharmaceuticals Appoints New Member to Company’s Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Feb 2015
Shire Acquires Meritage Pharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Sep 2014
Nabriva Therapeutics Appoints Dr Colin Broom as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Mar 2014
Stem Cell Therapeutics Strengthens its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Jan 2014
Stem Cell Therapeutics Announces Appointment of Dr. Calvin R. Stiller as Chairman
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Jan 2014
NPS Pharmaceuticals Receives Orphan Drug Designation for Natpara(R) in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 29 Jan 2013
Amedica Announces Expansion Of Executive Team
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 21 Dec 2012
FDA Approves Gattex(R) (teduglutide [rDNA Origin]) for Injection for the Treatment of Adult Short Bowel Syndrome
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 4 Sep 2012
Revestive(R) (teduglutide) Receives European Marketing Authorization for the Treatment of Adults with Short Bowel Syndrome (SBS)
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 22 Jun 2012
Takeda Receives Positive CHMP Opinion for Teduglutide (Revestive(R)) for Patients with Short Bowel Syndrome
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 29 Feb 2012
NPS Pharmaceuticals Appoints Georges Gemayel, Ph.D., to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Sep 2011
NPS Pharmaceuticals Appoints Eric Pauwels as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Sep 2011
IMMUNE Pharmaceuticals Announces Alan G. Harris MD, PhD, FRCP as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jan 2011
GATTEX(R) (teduglutide) Meets Primary Efficacy Endpoint in Phase 3 Pivotal Study in Patients with Adult Short Bowel Syndrome
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 6 Jul 2009
NeoStem, Inc. Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs
Regenerative Medicine Personnel
 HSMN NewsFeed - 8 Oct 2008
One Year of GATTEX(TM) Therapy Safely Reduces Parenteral Nutrition Dependence for Patients with Short Bowel Syndrome
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 9 Sep 2008
Jennerex Completes $8.3 Million Series B Financing and Appoints Dr. Cal Stiller as Director
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 15 Aug 2008
Onyx Pharmaceuticals Names Juergen Lasowski, Ph.D. as Senior Vice President of Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jul 2008
Barr Confirms Patent Challenge of Sensipar(R) Tablets, 30mg, 60mg and 90mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 19 May 2008
Phase 3 GATTEX(TM) Results Presented at Annual Digestive Disease Week Congress Highlight Potential New Treatment in Short Bowel Syndrome
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 17 Mar 2008
NPS Reports Successful GATTEX(TM) Extension Study
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 26 Feb 2008
NPS Pharmaceuticals Announces Senior Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Feb 2008
Onyx Pharmaceuticals Names N. Anthony Coles, M.D. as President, Chief Executive Officer and Member of its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jan 2008
NPS Pharmaceuticals Announces Board Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jan 2008
NPS Pharmaceuticals Appoints Dr. Alan G. Harris Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Nov 2007
NPS Pharmaceuticals Announces Senior Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Oct 2007
NPS Pharmaceuticals Names Douglas N. Dobak Vice President of Regulatory Affairs and Drug Safety
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Oct 2007
Phase Bioscience Announces Series B Investment from Johnson & Johnson Development Corporation, Fletcher Spaght Ventures and Hatteras Venture Partners
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Oct 2007
NPS Pharmaceuticals Names Brian O'Callaghan as New Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Sep 2007
NPS Pharmaceuticals and Nycomed Announce Licensing Agreement for GATTEX(TM) in Territories Outside North America
Biopharmaceuticals Gastroenterology Licensing
 HSMN NewsFeed - 19 Sep 2007
PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Sep 2007
VLST Corp Names Consuelo M. Blosch, M.D., Vice President of Clinical and Regulatory and Dan Allison, Ph.D., Sr. Director of Therapeutic Design
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jul 2007
NPS Pharmaceuticals Expands Agreement with European Partner Nycomed to Include Broader Territory Rights for Preotact(R)
Biopharmaceuticals Distribution Licensing
 HSMN NewsFeed - 3 Jul 2007
NPS Appoints Francois Nader, M.D., to Executive Vice President and COO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jul 2006
Lipocine Inc. Announces Strengthening of Its Senior Management Team With Addition of Robert Merrell as Vice President of Finance
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 33

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 33 additional stories matching:
NPS Pharmaceuticals
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.